This market value does not include the contrast injector segment, as it is a capital-based market instead of consumable-based. In 2015, the MRI contrast agent segment comprised the largest portion of this market. Despite having a lower sales volume, the higher ASP of MRI contrast agents compared to X-Ray CT contrast agents, has allowed this segment to increase in market share. Conversely, stagnant unit growth and decreasing ASPs has caused the X-Ray CT contrast agent segment to experience a decline in market share. Ultrasound contrast agents command the highest ASP and will exhibit a gradually increasing market share driven by sales growth.
The U.S. market for contrast agents and injectors includes X-ray and CT agents, MRI agents and ultrasound agents as well as contrast injectors. In 2015, MRI contrast agents represented the largest segment in the contrast agent and injector market. This segment will continue to have the highest market value driven by increasing procedural volumes.
- GE Healthcare
- Siemens Healthcare
- Philips Healthcare
- Toshiba Medical Systems
Others include: Accutome, Agfa Healthcare, Amrad Medical, Analogic, Arcoma-IMIX, Assured Imaging Mobile Mammography, BK Medical, Bracco, C.R. Bard, Canon, Carestream Health, CMR-Naviscan, Cuattro, Del Medical, Digirad, Dilon Technologies, Ellex/Innovative Imaging, Esaote, eZono, Fischer-Giotto, FONAR, Fujifilm, Gamma Medica Inc., Guerbet, Hitachi Medical Systems, iCRco, Imaging Dynamics Company, IMRIS, Konica Minolta, Lakeshore Technologies Inc., Lantheus Medical Imaging, Machnet B.V., Mallinckrodt, MILabs, Mindray, Neusoft Medical Systems, Paradigm, Planmed OY, Quantel Medical, Rayence, Samsung Medison, Shimadzu, SonoCiné, Sonogage, Sonomed Escalon, SonoSite, Spectrum Dynamics Medical, SuperSonic Imagine, SuperSonic Imagine, Swissray, Teleflex, Terason, Tomey, TXR, ViewRay, Zonare, etc.